» Articles » PMID: 29979449

The Appropriate Management Algorithm for Diabetic Foot: A Single-center Retrospective Study over 12 Years

Overview
Specialty General Medicine
Date 2018 Jul 7
PMID 29979449
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetic foot management is a challenge for reconstructive surgeons because it combines dramatically decreased circulation and chronic infection. The goal of managing this condition is to maximize viable tissue; however, unsatisfactory results, such as extremity amputation, are unavoidable in some cases. For appropriate management, thorough understanding of diabetic foot and the phased approach to its management is needed. The purpose of this study is to introduce an optimal algorithm for diabetic foot management by analyzing cases >12 years.

Methods: A total of 274 patients with diabetic foot at Hanyang University Guri Hospital from 2005 to 2017 were reviewed. The management process was divided into 5 steps: patient evaluation, wound preparation, improving vascularity, surgery and dressing, and rehabilitation. Patient evaluation included a microbial culture, evaluation of vascularity, and an osteomyelitis assessment. During wound preparation, debridement and negative-pressure wound therapy were performed. Vascularity was improved by radiological intervention or surgical method. Surgery and dressing were performed depending on the indications. Rehabilitation was started after complete wound healing.

Results: An infection was confirmed in 213 of 263 patients (81.0%). Of 74 cases in which a vascular study was performed, 83.8% showed arterial occlusion. When surgery was performed with complete eradication of the infection in 155 patients, the rate of revision surgery was 20.6%. The revision rate after surgery with a remnant infection of 66 patients was 40.9% (P = .0003). When surgery was performed after successful revascularization for improving blood flow of 47 patients, the rate of revision surgery was 21.3%. In contrast, the revision rate after surgery with unsuccessful or no revascularization of 174 patients was 28.2% (P = .359).

Conclusion: Diabetic foot is a debilitating disease arising from multifactorial process. As its management is complex, a comprehensive but accessible treatment algorithm is needed for successful results. For this reason, the appropriate algorithm for diabetic foot management introduced in this study is significant.

Citing Articles

The influence of primary and subsequent limb amputation on the overall rate of limb amputation in Saskatchewan, Canada, 2006-2019: a population-based study.

Kwaku Essien S, Linassi A, Farnan C, Collins K, Zucker-Levin A BMC Surg. 2021; 21(1):385.

PMID: 34717614 PMC: 8557533. DOI: 10.1186/s12893-021-01381-2.


Diabetic foot and peripheral arterial disease. Single centre experience.

Altoijry A, Alghofili H, Alanazi S, AlHindawi D, AlAkeel N, Julaidan B Saudi Med J. 2021; 42(1):49-55.

PMID: 33399171 PMC: 7989311. DOI: 10.15537/smj.2021.1.25640.


Species-Specific Immunoassay Aids Identification of Pathogen and Tracks Infectivity in Foot Infection.

Hao S, Masters E, Ninomiya M, Beck C, Schwarz E, Daiss J Foot Ankle Int. 2020; 42(3):363-372.

PMID: 33161780 PMC: 7946706. DOI: 10.1177/1071100720965136.


Flexible electrical stimulation device with Chitosan-Vaseline® dressing accelerates wound healing in diabetes.

Wang X, Li M, Fang Q, Zhao W, Lou D, Hu Y Bioact Mater. 2020; 6(1):230-243.

PMID: 32913931 PMC: 7451868. DOI: 10.1016/j.bioactmat.2020.08.003.


Clinical, Pathological and Microbiological Evaluation of Diabetic Foot Syndrome.

Uivaraseanu B, Bungau S, Tit D, Fratila O, Rus M, Maghiar T Medicina (Kaunas). 2020; 56(8).

PMID: 32731610 PMC: 7466372. DOI: 10.3390/medicina56080380.

References
1.
Shen G, Park I, Song Y, Joo H, Lee Y, Shin J . Local injection of granulocyte-colony stimulating factor accelerates wound healing in a rat excisional wound model. Tissue Eng Regen Med. 2019; 13(3):297-303. PMC: 6170830. DOI: 10.1007/s13770-016-9054-9. View

2.
Khalilpourfarshbafi M, Hajiaghaalipour F, Selvarajan K, Adam A . Mesenchymal Stem Cell-Based Therapies against Podocyte Damage in Diabetic Nephropathy. Tissue Eng Regen Med. 2019; 14(3):201-210. PMC: 6171601. DOI: 10.1007/s13770-017-0026-5. View

3.
Lipsky B, Berendt A, Deery H, Embil J, Joseph W, Karchmer A . Diagnosis and treatment of diabetic foot infections. Plast Reconstr Surg. 2006; 117(7 Suppl):212S-238S. DOI: 10.1097/01.prs.0000222737.09322.77. View

4.
Citron D, Goldstein E, Merriam C, Lipsky B, Abramson M . Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol. 2007; 45(9):2819-28. PMC: 2045270. DOI: 10.1128/JCM.00551-07. View

5.
Calhoun J, Cantrell J, Cobos J, Lacy J, Valdez R, Hokanson J . Treatment of diabetic foot infections: Wagner classification, therapy, and outcome. Foot Ankle. 1988; 9(3):101-6. DOI: 10.1177/107110078800900301. View